Outperformance of private sector banks may continue for next one year: Sandip Sabharwal

June 24, 2024

The smaller pharma companies I find it tough to evaluate, so many of them can potentially do well but I do not have the bandwidth to go molecule by molecule and evaluate those companies. But I think Sun Pharma is a decent business model, so we are just holding it for the long term.

More To Explore

Neville Noronha quits Avenue Supermarts, Unilever’s Anshul Asawa to be new CEO

Neville Noronha, CEO of Avenue Supermarts, will not renew his contract ending in January 2026 after leading the company for over two decades. Anshul Asawa

January 11, 2025

DMart Q3 Results: Standalone profit up 6.5% to Rs 785 crore, revenue jumps 17.5%

The retailer’s EBITDA margin fell to 7.9% in Q3FY25 as compared to 8.5% in Q3FY24 while the PAT margin also decreased to 5% vs 5.5%

January 11, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003